BRISBANE, AUSTRALIA, 13 December 2023 – MGI Australia, a subsidiary of MGI Tech Co. Ltd. (MGI), a global leader in life science technology, is pleased to announce a substantial expansion of its Brisbane Customer Experience Centre (CEC), now offering Australian and New Zealand researchers first access to MGI’s cutting-edge DNA, Cell and Spatial Omics (DCS) capabilities. This marks the first market outside China to access this revolutionary capability.
The Customer Experience Centre, established in 2021, was launched to give users in Australia and New Zealand (ANZ) unique access to MGI’s innovative technology portfolio, including the proprietary DNBSEQ™ platforms, laboratory automation systems, and bioinformatics appliances.
After two years of continuous commitment to innovation, the CEC has undergone a significant expansion to further support research efforts in the region. It now proudly stands as the inaugural CEC with DCS Lab products outside MGI’s home market in China.
“We are excited to support the Australian and New Zealand research community in accessing and evaluating the DCS facility solution,” said Dr Haofei Wang, Manager of the CEC with DCS Lab products in Brisbane. “Scientists will now be able to see the solution in operation before rapidly implementing it in their own institutes.”
The DCS Lab, powered by the core technologies of DNBSEQ™, is a revolutionary program designed to elevate research capabilities for emerging scientific leaders worldwide. Distinguished by its seamless integration of three advanced technologies, the program delivers foundational discovery tools in DNA sequencing, single-cell omics, and spatial transcriptomics.
Designed for operational efficiency, the DCS Lab accelerates research timelines by years through a streamlined delivery process. By eliminating the integration complexities associated with diverse platforms, it establishes a stable foundation for the rapid adoption of new capabilities. Participants benefit from dedicated support, ensuring optimal functionality of proven technologies, including the DNBelab-C4 and DNBelab C-TaiM 4RS single-cell solutions, and STOmics Stereo-seq spatial multi-omics technology. The DCS Lab can be tailored to specific throughput needs, and its exceptional expandability allows seamless integration of new capabilities, providing adaptability to evolving research requirements. This program not only propels research forward but also grants early access to MGI’s latest innovations, positioning research teams at the forefront of technological advancements.
“Our commitment to advancing scientific research in the ANZ region has driven the evolution of our Customer Experience Centre,” said Dr Bicheng Yang, Director of MGI Australia. He highlights the lab’s dual role as a Research and Development centre, focusing on innovative application development with regional significance. “We are thrilled to introduce the Customer Experience Centre with DCS capabilities in Australia. This facility represents a significant leap forward in the convergence of DNA, cell, and spatial-omics technologies, providing researchers with first-hand access to the tools and technologies that drive ground-breaking discoveries.”
The Customer Experience Centre in Australia solidifies MGI’s position as a leader in genomics innovation, ushering in a new era of scientific exploration and discovery. Positioned as a catalyst for collaborative research endeavours, the facility is poised to drive advancements with far-reaching impacts across medicine, environmental science, cancer research, agriculture, and beyond.
For access enquiries, contact Richard Harrison at richardharrison@mgi-tech.com
or +61 42 457 456.
